Chunlan Zhang

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Clinicopathological characteristics and therapeutic outcomes of Kimura disease: A real-world study.

Clinicopathological characteristics and therapeutic outcomes of Kimura disease: A real-world study.

Journal: British journal of haematology

Published: February 09, 2026

Pharmacologic modulation of the SAT1-N1-acetylspermidine axis is associated with enhanced chemotherapy cytotoxicity in T-LBL/ALL cells.

Pharmacologic modulation of the SAT1-N1-acetylspermidine axis is associated with enhanced chemotherapy cytotoxicity in T-LBL/ALL cells.

Journal: Biochemical pharmacology

Published: January 18, 2026

Mecapegfilgrastim for Prophylaxis of Immunochemotherapy-Induced Neutropenia in Patients With Diffuse Large B-Cell Lymphoma: A Multicenter Pilot Trial.

Mecapegfilgrastim for Prophylaxis of Immunochemotherapy-Induced Neutropenia in Patients With Diffuse Large B-Cell Lymphoma: A Multicenter Pilot Trial.

Journal: Cancer medicine

Published: September 17, 2025

Identification and prognostic prediction of high-risk multiple myeloma by exosomal microRNA.

Identification and prognostic prediction of high-risk multiple myeloma by exosomal microRNA.

Journal: Frontiers in oncology

Published: July 07, 2025

Predicting one-year overall survival in patients with AITL using machine learning algorithms: a multicenter study.

Predicting one-year overall survival in patients with AITL using machine learning algorithms: a multicenter study.

Journal: Scientific reports

Published: July 02, 2025

Evaluation of anti-CD38 monoclonal antibody-based immunotherapy in multiple myeloma with renal insufficiency: a systematic review and meta-analysis.

Evaluation of anti-CD38 monoclonal antibody-based immunotherapy in multiple myeloma with renal insufficiency: a systematic review and meta-analysis.

Journal: Therapeutic advances in hematology

Published: October 14, 2024

Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm.

Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm.

Journal: Frontiers in pharmacology

Published: May 20, 2024

MEG3 in hematologic malignancies: from the role of disease biomarker to therapeutic target.

MEG3 in hematologic malignancies: from the role of disease biomarker to therapeutic target.

Journal: Pharmacogenetics and genomics

Published: May 14, 2024

ALKBH5 promotes T-cell acute lymphoblastic leukemia growth via m6A-guided epigenetic inhibition of miR-20a-5p.

ALKBH5 promotes T-cell acute lymphoblastic leukemia growth via m6A-guided epigenetic inhibition of miR-20a-5p.

Journal: Experimental cell research

Published: May 12, 2024

Survival trend and outcome prediction for pediatric Hodgkin and non-Hodgkin lymphomas based on machine learning.

Survival trend and outcome prediction for pediatric Hodgkin and non-Hodgkin lymphomas based on machine learning.

Journal: Clinical and experimental medicine

Published: April 24, 2024

Changes in the clinical features, treatments, and outcomes of patients with systemic light chain (AL) amyloidosis in Western China, 2010-2022: A multicenter, retrospective, real-world study.

Changes in the clinical features, treatments, and outcomes of patients with systemic light chain (AL) amyloidosis in Western China, 2010-2022: A multicenter, retrospective, real-world study.

Journal: Chinese medical journal

Published: December 07, 2023

Long non-coding RNA MALAT1 in hematological malignancies and its clinical applications.

Long non-coding RNA MALAT1 in hematological malignancies and its clinical applications.

Journal: Chinese medical journal

Published: November 17, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026